Mirae Asset Global Investments’s Alexco Resource Corp AXU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,087,460
Closed -$1.63M 2706
2022
Q2
$1.63M Buy
4,087,460
+820,356
+25% +$797K ﹤0.01% 1207
2022
Q1
$5.06M Buy
3,267,104
+142,413
+5% +$237K 0.01% 868
2021
Q4
$5.44M Buy
3,124,691
+281,936
+10% +$510K 0.01% 865
2021
Q3
$4.26M Sell
2,842,755
-385,056
-12% -$735K 0.01% 893
2021
Q2
$8.07M Buy
3,227,811
+285,714
+10% +$803K 0.02% 706
2021
Q1
$7.38M Buy
2,942,097
+279,307
+10% +$768K 0.03% 641
2020
Q4
$8.44M Sell
2,662,790
-234,676
-8% -$617K 0.03% 529
2020
Q3
$7.65M Buy
2,897,466
+700,935
+32% +$1.93M 0.04% 457
2020
Q2
$4.94M Buy
2,196,531
+299,388
+16% +$554K 0.03% 505
2020
Q1
$2.31M Sell
1,897,143
-218,252
-10% -$369K 0.02% 614
2019
Q4
$4.91M Sell
2,115,395
-86,692
-4% -$160K 0.03% 519
2019
Q3
$3.81M Buy
2,202,087
+596,404
+37% +$1.1M 0.03% 537
2019
Q2
$1.83M Buy
+1,605,683
New +$1.68M 0.01% 727

Other funds holding AXU

Mirae Asset Global Investments's AXU Position: Q3 2022 in Review

Mirae Asset Global Investments sold out of Alexco Resource Corp (AXU) in Q3 2022, closing a stake of 4,087,460 shares — an estimated $1.63M sold.

Mirae Asset Global Investments first reported a position in AXU in Q2 2019 and held it in 13 quarters. The position peaked at $8.44M in Q4 2020. 2 funds tracked by Wall St. Rank hold AXU as of Q3 2022.

  • Mirae Asset Global Investments reported no remaining Alexco Resource Corp position as of Q3 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,087,460 Alexco Resource Corp shares in Q3 2022, an estimated $1.63M.
  • Mirae Asset Global Investments first reported a position in Alexco Resource Corp in Q2 2019 and held it in 13 quarters.
  • Mirae Asset Global Investments's Alexco Resource Corp position peaked at $8.44M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Alexco Resource Corp as of Q3 2022.

Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.